Biomedical Photonics (Jun 2018)

THE ROLE OF PHOTODYNAMIC THERAPY IN THE TREATMENT OF PRIMARY, RECURRENT AND METASTATIC MALIGNANT BRAIN TUMORS

  • D. A. Tzerkovsky,
  • E. A. Maslakov,
  • D. A. Bagrintsev,
  • I. A. Semak,
  • Yu. L. Protopovich,
  • A. G. Chizh,
  • A. A. Tatur,
  • I. S. Fomenkov,
  • D. S. Stupak

DOI
https://doi.org/10.24931/2413-9432-2018-7-2-37-49
Journal volume & issue
Vol. 7, no. 2
pp. 37 – 49

Abstract

Read online

Photodynamic therapy is a relevant and promising area for research in the field of clinical neuroonocology. Application of modern developments in the field of laser technologies and new photosensitizers allows us to refer to this field as to high-tech. According to various authors, the inclusion of photodynamic therapy in combined and complex treatments of patients with malignant brain tumors allows achieving overall survival median of patients from 11 to 26 months for primary form of glioblastoma, and from 7.5 to 15 months - for recurrent forms of glioblastoma. Certain results have been achieved in the treatment of patients with metastatic brain lesion. In this publication the authors analyzed and systematized the results of the main clinical studies in the field of fluorescent diagnostics and intraoperative photodynamic therapy of primary, recurrent and metastatic forms of malignant brain tumors.

Keywords